The National Cancer Institute (NCI) awarded a $191,700 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Northwestern University. The 5-year grant, which began on January 15, 2025, will support a pilot trial to assess the feasibility, acceptability, and effects of four digital intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) aimed at increasing HPV vaccination rates among the U.S. Vietnamese population. The...
This Project Grant award, valued at $233,411.00, was awarded by the National Cancer Institute (NCI) under the federal grant program "Cancer Cause and Prevention Research" (CFDA 93.393). The grant aims to evaluate the impact of a narrative communication intervention delivered through digital and mobile technologies on HPV vaccine initiation rates among 9- to 12-year-old children. The study, titled "STORIES TO PREVENT (STOP) HPV CANCERS," will recruit cancer survivors to film...
This $4,947,572 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a cohort study to evaluate the effectiveness of the HPV vaccine in preventing anogenital disease among immunocompromised populations. The study will assess vaccine effectiveness across three distinct groups: people living with HIV, people with autoimmune conditions, and people with a history of solid...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $170,639 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award, with a period of performance from September 1, 2024 to May 31, 2028, will fund research to (1) characterize barriers to pediatric dolutegravir combination therapy adherence, and (2) estimate per-protocol effects of treatment...
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $630,506 to The Johns Hopkins University to develop novel therapeutic cancer vaccines targeting human papillomavirus (HPV) for the treatment of cervical cancer. The primary goal is to employ spontaneous HPV cervicovaginal carcinoma models to characterize immune evasion mechanisms of HPV E6/E7 variants and evaluate the efficacy of a DNA vaccine against different HPV16 variants. The...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $1,349,998 Cooperative Agreement from the Center for State, Tribal, Local, and Territorial Support, a component of the Centers for Disease Control and Prevention (CDC). The award, which runs from September 30, 2024 to September 29, 2029, is part of the CDC's Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135). Under this Cooperative Agreement, UNC-CH will establish and...
This federal Project Grant award in the amount of $1,511,536.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a testis cancer survivorship study to be conducted by the University of North Carolina at Chapel Hill (UNC-CH) over a 4-year period from July 1, 2024 to June 30, 2028. UNC-CH, through its Office of Sponsored Research, will deliver high-quality research and innovative solutions to address complex...
The University of North Carolina at Chapel Hill will receive $3,863,892 under a four-year Project Grant from the Defense Health Agency to integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The grant, awarded on September 15, 2023 under the Military Medical Research and Development program, will support the university's efforts to transform military and public health care by investigating medical solutions for the battlefield and innovative research...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $3,229,456 to Kaiser Foundation Hospitals to implement a 5-year "MULTILEVEL PEER-TO-PEER EDUCATION PROGRAM TO INCREASE HPV VACCINATIONS AND WELLNESS IN SCHOOL BASED HEALTH CENTERS (PEER)." The project aims to improve HPV vaccination rates and utilization of school-based health centers (SBHCs) among medically...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $1,050,000 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award, effective September 30, 2024 through September 29, 2029, will support efforts to engage school communities in preventing exemptions to kindergarten vaccination mandates. As a leading public research university, UNC-CH will leverage its...